• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 399-413 of 1,667 results

1039 Exhibit: Heimann 2007

Document IPR2024-00201, No. 1039 Exhibit - Heimann 2007 (P.T.A.B. Nov. 20, 2023)

cite Cite Document
Analyze

1012 Exhibit: 601 patent PH 4

Document IPR2024-00201, No. 1012-4 Exhibit - 601 patent PH 4 (P.T.A.B. Nov. 20, 2023)

cite Cite Document
Analyze

1038 Exhibit: Rosenfeld 2006

Document IPR2024-00201, No. 1038 Exhibit - Rosenfeld 2006 (P.T.A.B. Nov. 20, 2023)

cite Cite Document
Analyze

1027 Exhibit: Richard F Spaide et al 2009

Document IPR2023-00533, No. 1027 Exhibit - Richard F Spaide et al 2009 (P.T.A.B. Feb. 10, 2023)

cite Cite Document
Analyze

1094 Exhibit: ClinicalTrialsgov, 1997 Congress Passes Law FDAMA Oct 2020

Document IPR2023-00533, No. 1094 Exhibit - ClinicalTrialsgov, 1997 Congress Passes Law FDAMA Oct 2020 (P.T.A.B. Feb. 10, 2023)

cite Cite Document
Analyze

1009 Exhibit: US Patent No 7,396,664 B2

Document IPR2023-00533, No. 1009 Exhibit - US Patent No 7,396,664 B2 (P.T.A.B. Feb. 10, 2023)

cite Cite Document
Analyze

M02NANWUWFYBX93

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. M02NANWUWFYBX93 (U.S. Pat. App. Aug. 20, 2024)

cite Cite Document
Analyze

LYGCJPSVXBLUEX2

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LYGCJPSVXBLUEX2 (U.S. Pat. App. Jul. 10, 2024)

cite Cite Document
Analyze

M0QL9PM6WFYBX92

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. M0QL9PM6WFYBX92 (U.S. Pat. App. Sep. 6, 2024)

cite Cite Document
Analyze

LZ8N1BMTWFYGX52

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LZ8N1BMTWFYGX52 (U.S. Pat. App. Jul. 30, 2024)

cite Cite Document
Analyze

LZ8N1AI6WFYGX51

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LZ8N1AI6WFYGX51 (U.S. Pat. App. Jul. 30, 2024)

cite Cite Document
Analyze

LYGCJPSUXBLUEX2

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LYGCJPSUXBLUEX2 (U.S. Pat. App. Jul. 10, 2024)

cite Cite Document
Analyze

LYGCJPSTXBLUEX2

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LYGCJPSTXBLUEX2 (U.S. Pat. App. Jul. 10, 2024)

cite Cite Document
Analyze

LKJGS8GLGREENX4

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LKJGS8GLGREENX4 (U.S. Pat. App. Jul. 25, 2023)

cite Cite Document
Analyze

LR6TSSVAGREENX7

Document USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LR6TSSVAGREENX7 (U.S. Pat. App. Jan. 9, 2024)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 27 28 29 30 31 ... >>